相关产品推荐更多 >

APC Mouse anti-Human CD194(CCR4) Antibody(1G1)【APC 鼠抗人 CD194(CCR4)抗体(1G1)】- abs1841231
¥1400
CD31 Mouse mAb (S-934-6)【CD31小鼠单克隆抗体(S - 934 - 6)】
¥600
PerCP Mouse anti-Human CD64 Antibody(10.1)【PerCP 鼠抗人 CD64 抗体(10.1)】- abs1841155
¥1150
Rabbit anti-Cathepsin B Polyclonal Antibody【兔抗组织蛋白酶B多克隆抗体】
询价
Rabbit anti-NCR1 Polyclonal Antibody【兔抗NCR1多克隆抗体】
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名:
Rabbit anti-ATP Citrate lyase Polyclonal mAb
- 抗体英文名:
Rabbit anti-ATP Citrate lyase Polyclonal Antibody
- 靶点:
见优宁维官网
- 浓度:
见优宁维官网
- 应用范围:
WB: 1:500-1:1000, IP: 1:20, IHC: 1:50-1:100, IF: 1:50-1:200, FCM: 1:50-1:100
- 宿主:
Rabbit
- 适应物种:
见优宁维官网
- 保质期:
见优宁维官网
- 抗原来源:
见优宁维官网
- 级别:
优级
- 库存:
999
- 供应商:
Absin
- 标记物:
Unlabeled
- 克隆性:
见优宁维官网
- 保存条件:
Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
- 免疫原:
A synthesized peptide derived from human ATP citrate lyase
- 规格:
100uL
别名:兔抗ATP柠檬酸裂解酶多克隆抗体
免疫原:A synthesized peptide derived from human ATP citrate lyase
应用:WB: 1:500-1:1000, IP: 1:20, IHC: 1:50-1:100, IF: 1:50-1:200, FCM: 1:50-1:100
保持条件:Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
使用方法:WB,IP,IHC,IF,FlowCytometry
标记:Unlabeled
宿主:Rabbit
反应种属:Human,Mouse,Rat
克隆性:见优宁维官网
产品描述:见优宁维官网
爱必信品牌介绍:

更多详情请了解优宁维网站》》
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Flow Cytometric Analysis Of Bcl Family members
against Bcl-xL (Santacruz Biotechnology, USA) and rabbit polyclonal against Bax (Santacruz Biotechnology, USA). The secondary AB against Bcl2 was goat anti mouse Ig FITC (Immunotech, USA) and against Bcl-xL and Bax goat anti rabbit FITC (ICN-Cappel, USA). FITC
通过线粒体膜,需要通过一个称为柠檬酸�丙酮酸循环(citrate pyruvate cycle)来完成乙酰CoA由线粒体到胞浆的转移。首先在线粒体内,乙酰CoA与草酰乙酸经柠檬酸合成酶催化,缩合生成柠檬酸,再由线粒体内膜上相应 载体 协助进入胞液,在胞液内存在的柠檬酸裂解酶(citrate lyase)可使柠檬酸裂解产生乙酰CoA及草酰乙酸。前者即可用于生成脂肪酸,后者可返回线粒体补充合成柠檬酸时的消耗。但草酰乙酸也不能自由通透线粒体内膜,故必须先经苹果酸脱氢酶催化,还原成苹果
that can lead to artifacts. The advantage to using exogenously expressed tagged proteins is the generally high specificity of the anti-tag antibody and the ease with which a negative control can be performed in which the exogenous protein is lacking.
技术资料暂无技术资料 索取技术资料





